How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?

CHUN-YI LULI-MIN HUANG2021-01-082021-01-0820110929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955584342&doi=10.1016%2fS0929-6646%2811%2960011-9&partnerID=40&md5=14e7c41713db0445b6c85aff75a74f33https://scholars.lib.ntu.edu.tw/handle/123456789/539945[SDGs]SDG3antibiotic agent; Pneumococcus vaccine; antibiotic resistance; cost benefit analysis; drug efficacy; human; immunity; incidence; lobar pneumonia; note; prevalence; serotype; Streptococcus pneumonia; vaccination; world health organizationHow many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?note10.1016/S0929-6646(11)60011-92-s2.0-79955584342